Definitive Healthcare (DH) Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025 summary

Market positioning and business overview

• Provides healthcare commercial intelligence to companies targeting the U.S. healthcare delivery system, a $4 trillion market.

• Revenue stands at $250 million, with a focus on differentiated physician and affiliation data.

• Leadership transition aims to drive a turnaround and return to growth.

• Customer relationships are strong, with high engagement and satisfaction among integrated users.

Strategic initiatives and operational changes

• Emphasizing differentiated data, deeper integration with partners, and improved customer renewal rates.

• Restructured post-sales and onboarding processes to align with vertical sales strategies for better retention.

• Integrated customer success and professional services into the sales process for a seamless customer experience.

• Early signs of improved new logo generation and sales productivity, though retention remains a key focus.

Market trends and competitive landscape

• Biopharma segment faces elongated sales cycles due to macroeconomic factors and clinical trial timing.

• Increased competition in medical devices from lower-priced entrants, but focus remains on quality and service.

• Diversified and provider segments show higher renewal rates and less competition.